October 26, 2026

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida, October 23, 2026 – Lunit Inc....

recent articles

I recently connected with Tim Bouvine on Facebook given our mutual interests in baseball, and in particular, the Chicago Cubs.  Tim Bouvine began sports-blogging in 2010 and loved his new pursuit of writing so much that he decided to broaden...

  Good news – digital pathology is transforming healthcare and the benefits are being seen by users and suppliers alike: Global digital pathology market set to reach $492 million by 2020 Advances in virtual microscopy is...

I think that liquid biopsy, that is, using urine or peripheral blood samples will revolutionize cancer care and pathology over time.  Right now testing may be more limited with limited clinical trials but over time I think liquid biopsy will...

Former Charles River Laboratories CSO broadens Flagship’s leadership expertise May 3, 2016 – Westminster, CO – Flagship Biosciences, the leader in tissue image analysis, announced the addition of Dr. Nancy Gillett to its Board of...

When? Saturday, September 3, 2016. Where? Den Hague, Netherlands (during ECCB2016) Website? http://cpw.pathomation.com Digital pathology is increasingly used to study biological processes and diseases as novel molecular probing and imaging...

I thought we covered this more than a year ago but a recent study published in the Annals of Internal Medicine with an accompanying editorial and an article written by Troy Brown, RN on Medscape, there has been some additional dissection of...

OR

platinum partners

gold partners

Silver Partners

Media Partners